Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

le 61 patients were 75 years and over. No overall differences in safety or effectiveness were observed between subjects 65 years and over and younger subjects. While this and other reported clinical experience have not identified differences in responses between the elderly and younger patients, greater sensitivity of some older individuals cannot be ruled out. This drug is known to be substantially excreted by the kidney. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection in the elderly, and it may be useful to assess renal function in these patients prior to initiating dosing and periodically thereafter (see Dosage and Administration (2.2); Clinical Pharmacology (12.3)). 10 OVERDOSAGE During controlled clinical trials in healthy subjects, single doses of up to 800 mg JANUVIA were administered. Maximal mean increases in QTc of 8.0 msec were observed in one study at a dose of 800 mg JANUVIA, a mean effect that is not considered clinically important (see Clinical Pharmacology (12.2)). There is no experience with doses above 800 mg in humans. In the event of an overdose, it is reasonable to employ the usual supportive measures, e.g., remove unabsorbed material from the gastrointestinal tract, employ clinical monitoring (including obtaining an electrocardiogram), and institute supportive therapy as dictated by the patient's clinical status. Sitagliptin is modestly dialyzable. In clinical studies, approximately 13.5% of the dose was removed over a 3- to 4-hour hemodialysis session. Prolonged hemodialysis may be considered if clinically appropriate. It is not known if sitagliptin is dialyzable by peritoneal dialysis. 11 DESCRIPTION JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. Sitagliptin phosphate is described chemically as 7-((3R)-3-amino-1-oxo-4-(2,4,5-trifluoro
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:5/1/2015)... -- Following yesterday,s release of Center for Medicaid and Medicare ... you need to know: ... government programs. , ... parts of Medicare and other government programs because it relies ... prescription drug benefits to enrollees. , Competition and rebates ...
(Date:5/1/2015)... PLEASANTON, Calif. , May 1, 2015  Thoratec Corporation ... support therapies to save, support and restore failing hearts, announced ... the newly created role of President, International. This ... all Thoratec commercial operations outside of North America ... Asia , and Latin America , ...
(Date:5/1/2015)... May 1, 2015  Legendary actor and director ... new PBAFacts campaign designed to educate and encourage patients ... about Pseudobulbar Affect (PBA) and to speak with their ... actor has the ability to cry and laugh on ... control experienced by people living with PBA episodes. ...
Breaking Medicine Technology:5 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 2Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA), a Little Known but Widespread Neurologic Condition 3
... Nov. 15, 2010 Spherix Incorporated (Nasdaq: ... diabetes and the metabolic syndrome, and a provider of ... and pharmaceutical companies, today reported results for the three ... and Upcoming Highlights Pharmaceutical Development ...
... 15, 2010 /PRNewswire-- Sangart, Inc., a global ... designed to enhance the perfusion and oxygenation of ... other gas delivery, today announced that its investigational ... designation by the U.S. Food and Drug Administration ...
Cached Medicine Technology:Spherix Announces Third Quarter 2010 Financial Results 2Spherix Announces Third Quarter 2010 Financial Results 3Spherix Announces Third Quarter 2010 Financial Results 4Spherix Announces Third Quarter 2010 Financial Results 5Spherix Announces Third Quarter 2010 Financial Results 6Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 2Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease 3
(Date:5/2/2015)... 02, 2015 It’s a pattern that ... disaster strikes anywhere on this planet, cyber scammers will ... and compassion for their own personal gain. And ... Readiness Team) issued an alert titled “Nepal Earthquake ... scams citing the earthquake in Nepal. The scam emails ...
(Date:5/2/2015)... 02, 2015 As a nonsurgical ... of the face, neck and décolleté, radiofrequency energy ... real potential for the success of vulvovaginal rejuvenation. ... Clinical Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory ... concluded that ThermiGyn’s temperature controlled radio frequency, specifically ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members ... federal support for telemedicine. , “Such action is ... with Congress,” said Jonathan Linkous, CEO of the American Telemedicine ... poised to embrace the use of telecommunications in the delivery ... ATA’s mission to improve quality, access, equity and affordability of ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up ... to help protect the rights of adolescent girls in India. ... added since Girl Up began almost five years ago – ... adolescent girls in the Rajasthan region of India. , ... advancement of adolescent girls in Guatemala, Ethiopia, Liberia, and Malawi. ...
Breaking Medicine News(10 mins):Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3
... homes, seniors increasingly turning to home care vs. assisted ... estate crisis has affected all aspects of life, and ... unable to sell their homes, moving to an assisted ... reason, the option of aging-in-place with retrofits is growing ...
... lead to blood clots, study says , , THURSDAY, Jan. ... don,t seem to increase the risk of heart disease as ... , But more research on the newer generations of contraceptives ... true because more women over age 35 are taking hormonal ...
... spending on health IT, Congress should first fix the ... control over their personal health information," says Sue A. ... "Right now, the HIPAA privacy rule has too ... Blevins stresses. , , IHF released ...
... cancer patient Debra Gardocki receives an injection from oncologist ... a new approach to treat advanced melanoma -- an ... limited effective treatment options. The study -- which is ... United States and Canada -- includes combining a therapeutic ...
... The $800 million settlement that Eli,Lilly and Company (NYSE: ... civil False Claims,Act charges related to allegedly false or fraudulent ... to the courageous stands taken by,employee whistleblowers, according to the ... The company,s settlement with the federal government, which also includes,a ...
... Awards ScholarshipWASHINGTON, Jan. 15 High ... chance to score some extra cash from got milk?(R) for ... with USA TODAY, has launched the 12th annual Scholar Athlete ... Awards reward 25 high school senior student athletes who demonstrate ...
Cached Medicine News:Health News:Housing Crisis Affects Seniors Needing Care 2Health News:Housing Crisis Affects Seniors Needing Care 3Health News:Newer Contraceptives Don't Increase Heart Risk 2Health News:Newer Contraceptives Don't Increase Heart Risk 3Health News:Economic Stimulus Package Could Impinge on Americans' Health Privacy 2Health News:A Shot in the Arm to Fight Skin Cancer 2Health News:Whistleblowers' Complaints Lead Eli Lilly to Pay $800 Million to Settle Civil Medicaid Fraud Charges, According to Berg & Androphy 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 2Health News:Video: Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 3
Combined Screen (RNP, Sm, Jo-1, Scl-70, SS-A, SS-B) ELISA kit....
... Scientific, Inc. ENA Screen ELISA test system ... detect antibodies to extractable nuclear antigens (anti-ENA) ... the directional insert, this test system is ... for, such as those against Jo-1, Sm, ...
... Single Well Screening Kit is designed to screen ... autoantibodies. Each microtiter well is coated with Sm, ... allows the laboratory to cost effectively screen out ... the ENA specificity on any of the company's ...
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
Medicine Products: